Tuesday
July 8, 2025
7:00 AM ET
Agios Appoints Dr. Jay Backstrom to Board of Directors
Wednesday
May 14, 2025
10:00 AM ET
Agios to Highlight Pyruvate Kinase Activation Portfolio with New Data in Rare Blood Disorders at 30th EHA Congress
Thursday
May 1, 2025
6:30 AM ET
Agios Reports First Quarter 2025 Financial Results and Recent Business Highlights
Thursday
April 17, 2025
7:00 AM ET
Agios to Webcast Conference Call of First Quarter Financial Results on May 1, 2025
Thursday
February 13, 2025
6:31 AM ET
Agios Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
Thursday
February 6, 2025
7:00 AM ET
Agios to Webcast Conference Call of Fourth Quarter and Full Year 2024 Financial Results on February 13, 2025
Monday
January 13, 2025
7:00 AM ET
Agios Announces Key 2025 Milestones for Innovative Rare Disease Portfolio